Practical implications of circadian variations in thrombolytic and antithrombotic activities. (Q41047300)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8724557%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

review article

1 reference

title

Practical implications of circadian variations in thrombolytic and antithrombotic activities (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8724557%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

0 references

1 reference

P B Kurnik

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8724557%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

publication date

1 May 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8724557%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8724557%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8724557%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8724557%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

page(s)

251-262

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8724557%20AND%20SRC:MED&resulttype=core&format=json

Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke

17 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970278-2

7 January 2021

Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1)

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970278-2

7 January 2021

Correlation of baseline plasminogen activator inhibitor activity with patency of the infarct artery after thrombolytic therapy in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970278-2

7 January 2021

Morning resistance to thrombolytic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970278-2

7 January 2021

Diurnal fluctuation of plasma-fibrinolytic activity in normal males

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970278-2

7 January 2021

Platelets and thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970278-2

7 January 2021

Circadian changes in anticoagulant effect of heparin infused at a constant rate

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970278-2

7 January 2021

Mechanisms contributing to increased synthesis of plasminogen activator inhibitor type 1 in endothelial cells by constituents of platelets and their implications for thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970278-2

7 January 2021

Diurnal changes in coronary blood flow in conscious dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970278-2

7 January 2021

Circadian variation in the success rate of intracoronary thrombolysis for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970278-2

7 January 2021

Differing circadian patterns of symptom onset in subgroups of patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970278-2

7 January 2021

A faster-acting and more potent form of tissue plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970278-2

7 January 2021

Circadian variation in the efficacy of tissue-type plasminogen activator.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970278-2

7 January 2021

Interactions of tissue-type plasminogen activator with plasma inhibitors and their pharmacologic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970278-2

7 January 2021

Dependence of fibrinolytic activity on the concentration of free rather than total tissue-type plasminogen activator in plasma after pharmacologic administration

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970278-2

7 January 2021

Circadian variation in the frequency of onset of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970278-2

7 January 2021

Circadian variation of acute myocardial infarction and the effect of low-dose aspirin in a randomized trial of physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970278-2

7 January 2021

Impairment of the diurnal fibrinolytic response in man. Effects of aging, type IV hyperlipoproteinemia, and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970278-2

7 January 2021

Plasminogen activators. The old and the new.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970278-2

7 January 2021

Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970278-2

7 January 2021

Modifiers of timing and possible triggers of acute myocardial infarction in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970278-2

7 January 2021

Circadian variations of plasma catecholamine, cortisol and immunoreactive insulin concentrations in supine subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970278-2

7 January 2021

Twenty-four hour pattern of the episodic secretion of cortisol in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970278-2

7 January 2021

Increased morning incidence of myocardial infarction in the ISAM Study: absence with prior beta-adrenergic blockade. ISAM Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970278-2

7 January 2021

10.1016/S0733-8651(05)70278-2

Identifiers

DOI

0 references

1 reference